Novavax to Participate in Upcoming September Conferences
Novavax (Nasdaq: NVAX), a global protein-based vaccine company, has announced its participation in two upcoming investor conferences in September 2024. The company will be present at the H.C. Wainwright 26th Annual Global Investment Conference on September 9, featuring a fireside chat and investor meetings. Additionally, Novavax will attend the Baird 2024 Global Healthcare Conference on September 10, delivering a presentation and holding investor meetings.
Key participants from Novavax include Jim Kelly, Executive Vice President, CFO and Treasurer, and Dr. Robert Walker, Senior Vice President, CMO and Interim Head of R&D. Both events will take place in New York City. Replays of the fireside chat and presentation will be available on the company's website for 30 days following the conferences.
Novavax (Nasdaq: NVAX), un'azienda globale specializzata in vaccini a base di proteine, ha annunciato la sua partecipazione a due conferenze per investitori in programma a settembre 2024. L'azienda sarà presente alla 26ª Conferenza Globale sugli Investimenti H.C. Wainwright il 9 settembre, con un incontro informale e incontri con gli investitori. Inoltre, Novavax parteciperà alla Conferenza Globale sulla Sanità Baird 2024 il 10 settembre, effettuando una presentazione e incontri con gli investitori.
I principali partecipanti di Novavax includono Jim Kelly, Vicepresidente Esecutivo, CFO e Tesoriere, e Dr. Robert Walker, Vicepresidente Senior, CMO e Capo Interinale della R&D. Entrambi gli eventi si svolgeranno a New York City. Le registrazioni dell'incontro informale e della presentazione saranno disponibili sul sito web dell'azienda per 30 giorni dopo le conferenze.
Novavax (Nasdaq: NVAX), una empresa global de vacunas basadas en proteínas, ha anunciado su participación en dos conferencias para inversores que se llevarán a cabo en septiembre de 2024. La empresa estará presente en la 26ª Conferencia Anual Global de Inversiones H.C. Wainwright el 9 de septiembre, con un chat junto a la chimenea y reuniones con inversores. Además, Novavax asistirá a la Conferencia Global de Salud Baird 2024 el 10 de septiembre, realizando una presentación y manteniendo reuniones con inversores.
Los participantes clave de Novavax incluyen a Jim Kelly, Vicepresidente Ejecutivo, CFO y Tesorero, y Dr. Robert Walker, Vicepresidente Senior, CMO y Jefe Interino de I+D. Ambos eventos se llevarán a cabo en la ciudad de Nueva York. Las repeticiones del chat junto a la chimenea y la presentación estarán disponibles en el sitio web de la empresa durante 30 días después de las conferencias.
Novavax (Nasdaq: NVAX), 단백질 기반 백신을 전문으로 하는 글로벌 회사가 2024년 9월에 열리는 두 개의 투자자 콘퍼런스에 참여할 것이라고 발표했습니다. 이 회사는 9월 9일에 H.C. Wainwright 제26회 글로벌 투자 컨퍼런스에 참석하여 파이어사이드 채팅과 투자자 회의를 진행합니다. 또한 Novavax는 9월 10일에 Baird 2024 글로벌 헬스케어 컨퍼런스에 참석하여 발표를 하고 투자자 회의를 가질 예정입니다.
Novavax의 주요 참가자로는 Jim Kelly, 집행 부사장, CFO 및 재무 이사, Dr. Robert Walker, 선임 부사장, CMO 및 연구개발 임시 책임자가 있습니다. 두 행사는 뉴욕시에서 열릴 예정입니다. 파이어사이드 채팅 및 발표의 재생 영상은 행사 후 30일간 회사 웹사이트에서 제공됩니다.
Novavax (Nasdaq: NVAX), une entreprise mondiale de vaccins à base de protéines, a annoncé sa participation à deux conférences pour investisseurs en septembre 2024. L'entreprise sera présente à la 26ème Conférence Annuelle Globale sur les Investissements H.C. Wainwright le 9 septembre, avec un échange informel et des réunions avec les investisseurs. De plus, Novavax assistera à la Conférence Mondiale sur la Santé Baird 2024 le 10 septembre, où elle présentera une communication et tiendra des réunions avec des investisseurs.
Les participants clés de Novavax incluent Jim Kelly, Vice-Président Exécutif, CFO et Trésorier, ainsi que Dr. Robert Walker, Vice-Président Senior, CMO et Responsable Intérimaire de la R&D. Les deux événements se dérouleront à New York. Les rediffusions de l'échange informel et de la présentation seront disponibles sur le site Web de l'entreprise pendant 30 jours après les conférences.
Novavax (Nasdaq: NVAX), ein global tätiges Unternehmen, das auf proteinbasierte Impfstoffe spezialisiert ist, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2024 bekannt gegeben. Das Unternehmen wird am 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright am 9. September teilnehmen, wo es ein Gespräch am Kamin und Investorenmeetings geben wird. Darüber hinaus wird Novavax am Baird 2024 Global Healthcare Conference am 10. September teilnehmen und eine Präsentation halten sowie Investorenmeetings abhalten.
Zu den wichtigsten Teilnehmern von Novavax gehören Jim Kelly, Executive Vice President, CFO und Treuhänder, sowie Dr. Robert Walker, Senior Vice President, CMO und Interimsleiter der F&E. Beide Veranstaltungen finden in New York City statt. Aufzeichnungen des Gesprächs am Kamin und der Präsentation werden 30 Tage nach den Konferenzen auf der Website des Unternehmens verfügbar sein.
- None.
- None.
H.C. Wainwright 26th Annual Global Investment Conference: | |||||
Fireside Chat | |||||
Date: | Monday, September 9, 2024 | ||||
Time: | 3:30 – 4:00 p.m. Eastern Time (ET) | ||||
Location: | |||||
Moderator: | Vernon Bernardino, Managing Director, Senior Healthcare Analyst | ||||
Novavax participants: | Jim Kelly, Executive Vice President, Chief Financial Officer and Treasurer and Robert Walker, MD, Senior Vice President, Chief Medical Officer and Interim Head, Research and Development | ||||
Conference | |||||
Event: | Investor Meetings | ||||
Date: | Monday, September 9, 2024 | ||||
Baird 2024 Global Healthcare Conference: | |||||
Presentation | |||||
Date: | Tuesday, September 10, 2024 | ||||
Time: | 3:10 – 3:40 p.m. ET | ||||
Location: | |||||
Novavax participants: | Jim Kelly, Executive Vice President, Chief Financial Officer and Treasurer and Robert Walker, MD, Senior Vice President, Chief Medical Officer and Interim Head, Research and Development | ||||
Conference | |||||
Event: | Investor Meetings | ||||
Date: | Tuesday, September 10, 2024 | ||||
A replay of the recorded fireside session and presentation will be available through the Events and Presentations page of the Company's website at ir.novavax.com for 30 days from the date of the conference.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in
Contacts:
Investors
Erika Schultz
240-268-2022
ir@novavax.com
Media
Giovanna Chandler
202-709-5563
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-upcoming-september-conferences-302237833.html
SOURCE Novavax, Inc.
FAQ
When is Novavax (NVAX) participating in the H.C. Wainwright Global Investment Conference?
What events will Novavax (NVAX) be involved in at the Baird 2024 Global Healthcare Conference?
Who will represent Novavax (NVAX) at these September 2024 conferences?
How long will the replays of Novavax's (NVAX) conference sessions be available?
